Human TSC22D1 Protein (His Tag)
Ptg-2,TGFB1I4,TSC22
- 100ug (NPP2560) Please inquiry
Catalog Number | P12724-H07E |
---|---|
Organism Species | Human |
Host | E. coli |
Synonyms | Ptg-2,TGFB1I4,TSC22 |
Molecular Weight | The recombinant human TSC22D1 consisting of 155 amino acids and has a calculated molecular mass of 17.2 kDa. It migrates as an 20 kDa band in SDS-PAGE under reducing conditions as predicted. |
predicted N | Met |
SDS-PAGE | |
Purity | > 92 % as determined by SDS-PAGE |
Protein Construction | A DNA sequence encoding the human TSC22D1 isoform 2 (Q15714-2) (Met 1-Ala 144) was expressed, with a polyhistidine tag at the N-terminus. |
Bio-activity | |
Research Area | Epigenetics |Transcription |Transcription Factor & Regulator |Basic Leucine Zipper (bZIP) Transcription Factors |
Formulation | Lyophilized from sterile PBS, pH 7.4 1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA. |
Background | TSC22 domain family, member 1 (TSC22D1) is one of the TGF-beta-stimulated clone-22 (TSC-22). TSC-22 was reported to be a differentiation-inducing factor which negatively regulates the growth of salivary gland cancer cells. TSC22D1, which encodes transforming growth factor beta-stimulated clone 22 (TSC-22), is thought to be a tumor suppressor because its expression is lost in many glioblastoma, salivary gland, and prostate cancers. TSC-22 is the founding member of the TSC-22/DIP/Bun family of leucine zipper transcription factors. TSC-22 may play an important role in maintaining the differentiated phenotype in salivary gland tumors, and may be a possible target of leukemia therapy. TSC22D1 forms homodimers via its conserved leucine zipper domain and heterodimerizes with TSC22D4. TSC22D1 has transcriptional repressor activity. |
Reference |